Navigation Links


division at medicine technology

When Volume Matters, Immunoassay Systems Deliver

...arge and small laboratories. Abbott Diagnostics, a division of Abbott Laboratories, Abbott Park, Ill., describes its AxSYM as the leading immunoassay system in the world. It is used in more than 10,000 laboratories across the globe. This system combines continuous access, random access and STAT processing wit...

Prothrombin Time Comes in Small (CLIA-Waived) Packages

...che Diagnostics Corporation, Indianapolis, Ind., a division of Swiss F. Hoffmann-La Roche Ltd, produces the CoaguChek S System, designed for health care professionals to enable on-the-spot analysis of coagulation levels during mobile emergency treatment, in hospital and in general practice. The device employs...

Lab Automation Networks Proliferating

...ration with analytic devices, Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland, says that its RSD 800 and RSD 800A Preanalytic Systems Manager (PSM) products offer state-of-the-art sample handling functions and powerful data management all from one system. The systems sample flow ...

Genetic Analysis Systems Enter the Clinical Mainstream

...ality of life. Vysis, Inc., Downers Grove, Ill., a division of Abbott Laboratories, has gained FDA approval for its Aneuvysion assay, the only FDA cleared product to test for prenatal aneuploidy. Vysis offers an expansive line of DNA FISH (fluorescence in situ hybridization) probes for evaluation of chromosom...

Hemoglobin Testing at the Point of Care

...th data management capabilities. GDS Technology, a division of Stanbio Laboratory, Boerne, Texas, produces the STATSite MHgb, based on the azidemethemoglobin method and able to use either finger stick or venous whole blood samples. The company says that this CLIA-waived device is the first palm-sized, battery...

Immunoassay Systems - Your Laboratory Workhorse

...rge and small laboratories. Abbott Diagnostics, a division of Abbott Laboratories, Abbott Park, Ill., describes its AxSYM as the leading immunoassay system in the world. It is used in more than 10,000 laboratories across the globe. This system combines continuous access, random access and STAT processing w...

Urinalysis Analyzers: Large Capabilities in Every Size Device

...mong urinalysis products from Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd., Basle, Switzerland, ...Chem is $625. Hypoguard USA, Inc., Edina, Minn., a division of British firm Medisys, manufactures the DiaScreen 50 Urine Chemistry Analyzer, designed for use wi...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

...igh unmet medical need. About Tibotec Tibotec, a division of Janssen-Cilag, brings innovative productsfor HI...nts in Europe, the Middle East and Africa.This new division was created within the Janssen-Cilag companies inOctober 2005 to focus on patients' and health care ...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

... ismarketed in the U.S. by Tibotec Therapeutics, a division of OrthoBiotech Products, L.P. In the European Uni...ther countries, PREZISTA is marketed by Tibotec, a division ofJanssen-Cilag. In Canada, PREZISTA is marketed by Tibotec, adivision of Janssen-Ortho Inc. Applica...

Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29

...orldwide by Janssen-Cilag (Janssen), awholly owned division of Johnson & Johnson; and VIVITROL(R)(naltrexone for extended-release injectable suspension) the firstand only once-monthly injectable medication approved for thetreatment of alcohol dependence and marketed in the U.S. primarilyby Cephalon, Inc. ...

Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

...s, Inc. (NASDAQ: PGNX) and WyethPharmaceuticals, a division of Wyeth (NYSE: WYE), today announcedpositive resu...ward-looking statements. Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron

...difficult-to-manufacturebiologics. Its Bioscience division helps to optimizelaboratory productivity and workflows. Its products and enablingtechnologies that are used in the laboratory are essential for theresearch and development of biologically based life sciencetherapeutics. Millipore has a deep understa...

First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy

...dquartered in Roanoke, Virginia. Luna nanoWorks, a division ofLuna Innovations, is located in Danville, Virginia. For more, seewww.lunainnovations.com. About VCU and the VCU Medical Center: Virginia CommonwealthUniversity is the largest university in Virginia and ranks amongthe top 100 universities in the co...

Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

...mgen and Wyeth Amgen and Wyeth Pharmaceuticals, a division of Wyeth, marketENBREL in North America. Wyeth mar...nes, visitwww.amgen.com. Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders

...generic products through its GlobalPharmaceuticals division and markets its branded products throughthe IMPAX Pharmaceuticals division. Additionally, wherestrategically appropriate, IMPAX has developed marketingpartnerships to fully leverage its technology platform. IMPAXLaboratories is headquartered in Haywa...

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

...veVice President, Oncology, Merck Serono – a division of MerckKGaA, Darmstadt, Germany. “We believe we have reached amilestone in oncology. Erbitux consistently adds meaningfulefficacy throughout all lines of mCRC therapy. The increasedresection rates we observed suggest a high potential to provid...

Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed

...rmal growth factor binds, causinguncontrolled cell division -- a predisposition for cancer. The EGFRis found at abnormally high levels on the surface of mostpancreatic cancer cells. This study examined the effectiveness ofCetuximab, an anticancer monoclonal antibody directed to block theEGFR, combined with th...

Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study

...ve Vice President, Oncology,Merck Serono – a division of Merck KGaA, Darmstadt,Germany. “Cilengitide is part of the Merck Serono Oncologyportfolio – led by the epidermal growth factorreceptor-targeting monoclonal antibody Erbitux® – and theclinical programs for these investigation...

New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings

... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. SOURCE Cordis Corporation Mariela Melendez of Cordis Corporation, +1-786-313-2776, cell, +1-786-218-4084,mmelen10@crdus.jnj.com; or Todd Ringler of Edelman, +1-6...

Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

...sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the Unite...

Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

Antidepressant Use May Boost Fracture Risk, From Harvard Women's Health Watch

...le from Harvard HealthPublications, the publishing division of Harvard Medical School,for $24 per year. Subscribe at <a target="_blank" href="http://www.health.harvard.edu/women">http://www.health.harvard.edu/women or by calling 1-877- 649-9457 (toll free). Media: Contact Christine Junge at for a com...

Mild Asthma, a Revolutionary Therapy from Italian Research

...he Italian company’sResearch and Development division – Over time this initialperception has become an increasingly evident rationale and hasgained significance in important clinical trials, such as the BESTstudy”. “On the basis of our daily experience, – explainsDr. Germano Bet...

Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent

...sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...

Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials

...sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...

New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia

...vayPharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth(NYSE:WYE), and Lundbeck A/S presented cli...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease

... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez of Cordis Corporation,+1-786-218-4084,; or Todd Ringler of Edelman, +1-617-872-1235,, forCordis Corporation <a target="_blank" href=...

New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder

...g in San Diego,Calif., by Wyeth Pharmaceuticals, a division of Wyeth . Resultsfrom short-term studies and a si...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo

...g in San Diego, Calif., by WyethPharmaceuticals, a division of Wyeth . The primary objective ofstudies include...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Gardasil Demonstrates Up to 100% Efficacy

...a joint venture between sanofi pasteur, thevaccine division of sanofi-aventis, and Merck & Co., Inc.Combining innovation and expertise, Sanofi Pasteur MSD is the onlycompany in Europe dedicated exclusively to vaccines. Sanofi PasteurMSD is able to draw on the research expertise of sanofi pasteur andMerck ...

Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats

... /PRNewswire-FirstCall/ -- WyethPharmaceuticals, a division of Wyeth , presented results from thefirst Phase 3...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies' Annual Meeting

...a strategic alliance with ChrysalisTechnologies (a division of Philip Morris USA) to develop andcommercialize aerosolized SRT to address a broad range of seriousrespiratory conditions. Through this alliance, Discovery gainedexclusive rights to Chrysalis' novel aerosol generating technologyfor use with pulmona...

Early Results of the CellCept Spare the Nephron Study Examine Kidney Function

...d Matthew Weir,M.D., professor and director of the division of nephrology at theUniversity of Maryland School of Medicine. "The preliminary studyresults are very encouraging." Dr. Weir reported that first-year results in kidney transplantrecipients demonstrated that patients on CellCept and sirolimusmainte...

Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron

...sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the US, B...

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

...sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the US, B...

Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show

... authors and associateprofessor of medicine in the division of clinical immunology andrheumatology and director of the university clinical researchcenter at the University of Texas Health Science Center, SanAntonio. "A reduction in pain is critical for people living withthis condition. With positive new data ...

First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability

...sedpharmaceuticals unit of Bayer HealthCare LLC, a division of BayerAG. One of the world's leading, innovative companies in thehealthcare and medical products industry, Bayer HealthCare combinesthe global activities of the Animal Health, Consumer Care, DiabetesCare, and Pharmaceuticals divisions. In the U.S.,...

Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter

...le from HarvardHealth Publications, the publishing division of Harvard MedicalSchool, for $59 per year. Subscribe at <a target="_blank" href="http://www.health.harvard.edu/mental">http://www.health.harvard.edu/mental or by calling 1-877-649-9457 (toll free). Media: Contact Christine Junge at for a co...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer

...angiogenesis; and KSP, a protein required for cell division that,when inhibited, leads to cell arrest and cell death in dividingcells. ALN-VSP01 is formulated using Alnylam's novel liposomalformulation technology, which has been used to achieve delivery ofsiRNAs to cells of the liver and efficient silencing o...

EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting

...ive, antimitotic agent that leads toarrest of cell division and apoptosis in tumor cells. ENMD-1198also exerts antiangiogenic activity that further contributes to itsoverall antitumor effects. Results demonstrate that oral administration of ENMD-1198 waswell tolerated and produced significant dose-dependen...

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

...tural network).Microtubules are necessary for cell division (mitosis), cellstructure, transport, signaling and motility. Given their primaryrole in cell division, microtubules have been an important targetfor anticancer drugs -- often referred to as tubulin inhibitors ormicrotubule targeting agents. These com...

Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 (R1645) is in Phase 1 clinical trialsin patients with solid tumors. Kosan's epothilone program ispartnered with Roche through a global deve...

Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver

...s being co-developed with Wyeth Pharmaceuticals, a division ofWyeth . These Phase 1b combination data demonstrate the additiveantiviral effects of HCV-796 across multiple genotypes of hepatitisC virus, in treatment-naïve adult subjects withchronic hepatitis C infection. HCV-796 dosed twice daily...

Cyclacel Pharmaceuticals to Present Preclinical Data on Sapacitabine and Seliciclib at AACR

...7 and CDK9, that are central to the process ofcell division and cell cycle control. Seliciclib has been evalua...le-strand DNA breaks and induces arrest ofthe cell division cycle. Both sapacitabine and its majormetabolite, CNDAC, have demonstrated in preclinical studies po...

Kosan Announces Data Presentations at Upcoming AACR Annual Meeting

... Phase 1 clinicaltrials. Epothilones inhibit cell division with a mechanism of actionsimilar to taxanes, one of the most successful classes ofanti-tumor agents. KOS-1584 is in Phase 1 clinical trials inpatients with solid tumors. Kosan's epothilone program is partneredwith Roche through a global development ...

New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy

... /PRNewswire-FirstCall/ --Wyeth Pharmaceuticals, a division of Wyeth , provides comment on are- analysis of po...the uterus. About Wyeth Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment

...d Pharmaceuticals divisions. The USPharmaceuticals division comprises the following business units:Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics,Hematology/Cardiology, and Oncology. The company's aim is todiscover and manufacture products that will improve human healthworldwide by diagnosin...

Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo

... /PRNewswire-FirstCall/ --Wyeth Pharmaceuticals, a division of Wyeth , SolvayPharmaceuticals, Inc. and Lundbec...ut Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading productsin the areas of women's health care, infectious disease,gastrointestin...

Cypher Sirolimus-eluting Coronary Stent Had Similar Results to Bypass Surgery in Long-Term Study of Patients With Multi-Vessel Coronary Artery Disease

... the stent, is marketed byWyeth Pharmaceuticals, a division of Wyeth, under the nameRapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez, Cordis Corporation, +1-786-313-2776,Cell:+1-786-218-4084, ; Todd Ringler, Edelman,+1-781-599-7542,Cell: +1-617-872-1235, <a target=...

Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke

...sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...

Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses

...the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune(R). Rapamune is a trademark of Wyeth Pharmaceuticals. CONTACT: Mariela Melendez of Cordis Corporation, phone,+1-786-313-2776,Cell: +1-786-218-4084, or Email: ; or Todd RinglerofEdelman for Cordis Corporation...

Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent

...sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...

Abbott's Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial

...sskit . About Abbott Vascular Abbott Vascular, a division of Abbott, is one of the world'sleading vascular care businesses. Abbott Vascular is uniquelyfocused on advancing the treatment of vascular disease andimproving patient care by combining the latest medical deviceinnovations with world-class pharmaceu...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

...ntenance of cell shape, cellular functions andcell division (growth). These highly dynamic filaments are composedof dimeric tubulin proteins. Microtubule targeting drugs are one ofthe most successful classes of chemotherapy agents and are used forboth solid and liquid tumors. There are three drug binding site...

Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility

...argeted to inhibit Aurorakinases thus halting cell division at the mitotic phase of the cellcycle and blocking the uncontrolled cellular proliferationassociated with tumor growth. Aurora kinases have been detected athigh levels in tumors from several cancer types, including colon,breast, ovarian, bladder, eso...
Other Contentsjointjointjointjointjointjointjointjointkaryotypekeratinkeratinkeratinkidneykidneykidneykidneykidneykidneykidneykidneykidneykinesiologykinetickinetickinetickinetickinetic
(Date:7/23/2008)...io Wealthy nations willing to collectively spend ...on of roughly half a billion metric tons of carbon...rch suggests. , It would take about that much m...restation in the world, one of the top contributor...e. , If adopted, this type of program could have...
(Date:7/23/2008)...d summit" will bring together internationally reno....S., Russia, China, Japan, Australia and India to... to Aug. 2. , "We are bringing together the w...e," said summit organizer J. William Schopf, found...s and Planetary Physics, Center for the Study of E...
(Date:7/23/2008)...t the National Institute of Standards and Technolo...e formation of clumps of proteins in protein-based...rifies the conditions under which scientists can b...asuring the formation of protein aggregates, a maj...l and safety in biologic drug manufacturing. , P...
(Date:7/23/2008)... scientists who set out to study sex pheromones in...nes also controls a stage in the worms, life cycle...published in Nature online on July 23, represent...e been linked through so-called small molecules. ...eins as the major players in an organism,s biology...
Breaking Biology News(10 mins):Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2NIST trumps the clumps: Making biologic drugs safer 2Sex and lifespan linked in worms 2Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 1Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 1Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 3Biking Walking Best for New Knees 13688 1Biking Walking Best for New Knees 13688 2Biking Walking Best for New Knees 13688 3ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 1ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 2ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 3
(Date:7/25/2008)...rogram delivers immediate cost savings for http:/...ess to language interpreters] to firms switching ...ns. , Washington, D.C. (...le-inc.com/index.html [(Language Learning Enterpr..., translation, and language instruction services t...
(Date:7/25/2008)...er you are an Olympian, Professional Athlete, Elit...s You Need to Know about Hydration to Boost Sports...enter , Marina del Rey, C...thletes are heading to Beijing following years of ...e hopes of capturing an Olympic medal and securing...
(Date:7/25/2008)...donation will be used to facilitate the planning a...en , Hauppauge, NY (PRWEB...leading integrator of enterprise collaboration sol...g, telepresence, audio visual integration, and man...t has donated video conferencing equipment to Mt. ...
(Date:7/24/2008)...archers at Wake Forest University Baptist Medical ...ief that the hepatitis C virus slows or stunts the...IV patients are treated with a combination of drug...infection is more serious in HIV-infected people, ...nters for Disease Control. Intravenous drug use is...
Breaking Medicine News(10 mins):Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3
Other TagsOutbreakOutbreakOvulationOther Tagsworthwhile 2worthwhile 3testicular 2testicular 3snacks 2snacks 3macular 2macular 3macular 4macular 5fast 2fast 3fast 4fast 5fast 6fast 7fast 8fast 9fast 10healthier 2gone 2gone 3gone 4keeping 2keeping 3keeping 4keeping 5keeping 6